USP7 and neoplasm: Almac4, another crucial USP7 inhibitor, has been shown to reduce tumor cell membrane PD-L1 levels, weaken the interaction between PD-L1 and PD-1, thereby rendering GC cells more sensitive to T cell-mediated cytotoxicity (Wang Z. et al., 2021).